ASPHO Summer Virtual Learning Series
July 2020 Webinar Series
Learn from 28 presenters at this special series featuring 2020 ASPHO Conference top-rated science abstracts and clinical recommendations for pediatric hematology/oncology. Don’t miss the opportunities for discovery, hear how to incorporate newly released science into your practice, and earn 8 AMA PRA Category 1 Credits™.
A live Q&A session follows each presentation, giving you the chance to pose your questions to each speaker. The webinars will take place each Wednesday in July from 1:00-3:00 PM CT starting on July 8.
Pricing for both individual sessions and the discounted bundle (includes all four sessions) can be found below. Members receive special rates for the Summer Virtual Learning Series. Not a member? Join today! Registrants will have exclusive access to the live presentations as well as access to the recordings.
|Individual Session||Bundle (purchase all sessions and save)|
|Trainee Member - $15||Trainee Member - $50 (save 20%)|
|Member - $30||Member - $80 (save 33%)|
|Non-member - $60||Non-member - $160 (save 33%)|
Links to purchase individual sessions can be found below each webinar's description.
ASH-ASPHO Choosing Wisely® List Presentation
Focusing on the pediatric hematology-focused Choosing Wisely® list, created in collaboration with the American Society of Hematology (ASH) and ASPHO, this session will provide a brief overview of the five evidence-based recommendations and their development, while highlighting strategies and talking points for advancing efficient care and implementation at your institution.
- Recall the methodology utilized to develop the Choosing Wisely® recommendations.
- Recognize the evidence to support the five evidence-based Choosing Wisely® recommendations, and potential impact on patient care.
- Use implementation strategies to incorporate recommendations into institutional practice to drive smart and effective care.
Sarah O’Brien, MD MSc
Cassandra D. Josephson, MD
Jacquelyn M. Powers, MD, MS
Clinical Aspects of Evaluating and Treating COVID-19 Patients in Pediatric Hematology/Oncology
This session will expand on the May ASPHO COVID-19 Webinar, with an in-depth focus on clinical cases highlighting the challenges of COVID-19 in pediatric hematology/oncology inpatients and consultations, including a discussion of emerging anticoagulation recommendations.
- Review the impact and current recommendations in the management of COVID-19 on the pediatric hematology/oncology ward
- Review anticoagulation recommendations in patients with COVID-19, including those with Multisystem Inflammatory Syndrome (MIS-C).
Glen Lew, MD
Jennifer Davila, MD
Claire L. Stokes, MD MPH
The weeks of July 15-29 will feature the top-rated abstracts selected for the 2020 ASPHO Conference.
- Discuss new approaches related to diagnosis and treatment in pediatric hematology/oncology.
- Examine current research outcomes from a variety of the latest in basic and clinical research
- Apply knowledge gained in all areas of pediatric hematology/oncology investigation and practice in patient care.
REDUCED FREQUENCY OF MAINTENANCE PULSES IN STANDARD-RISK B ACUTE LYMPHOBLASTIC LEUKEMIA AALL0932
Anne Angiolillo, MD
INCREASED EXPRESSION OF CXCR4 LEADS TO ENHANCED CELL MIGRATION IN CALM-AF10 DRIVEN LEUKEMIA
Jessica L. Heath, MD
Young Investigators Award Presentations
LEUKEMIA PREDISPOSITION OR CLONAL HEMATOPOIESIS IN SHWACHMAN DIAMOND SYNDROME: DIFFERENT PATHWAYS
Alyssa Kennedy, MD PhD
MECOM DYSREGULATION VIA ENHANCER HIJACKING IN PEDIATRIC THERAPY-RELATED MYELOID NEOPLASMS
Jason R. Schwartz, MD PhD
Oncology and HSCT/Cellular Therapy Papers
DISCOVERY OF A NOVEL RAL PATHWAY DISORDER (“RALOPATHY”) WITH EARLY ONSET MYELOPROLIFERATIVE DISEASE
Harry Lesmana, MD
GUT DECONTAMINATION ALTERS THE INTESTINAL MICROBIOTA DURING ALLOGENIC BONE MARROW TRANSPLANT
Christopher J. Severyn, MD, PhD
PROSPECTIVE TRIAL OF IBRUTINIB IN CHILDREN WITH CHRONIC GRAFT VERSUS HOST DISEASE
Sonali Chaudhury, MD
CD30-DIRECTED CAR T-CELLS FOR THE TREATMENT OF PEDIATRIC HODGKIN LYMPHOMA AND NON-HODGKIN LYMPHOMA
George E. Hucks Jr., MD
Basic and Translational Science – Oncology
ENHANCEMENT OF ANTI-TUMOR IMMUNITY BY T CELLS ENGINEERED TO RESTORE HLA EXPRESSION IN NEUROBLASTOMA
Fiorella Iglesias, MD
HIF EXPRESSION IN ANTIGEN-SPECIFIC AND CAR-T CELLS IMPROVES ANTITUMOR RESPONSE TO SOLID TUMORS
Colette Lauhan, MD
TARGETING ADENOSINE IN THE MARROW MICROENVIRONMENT AFFECTS STROMAL AND LEUKEMIA CELL SURVIVAL
Craig A. Mullen, MD PhD
Clinical Trials and Outcomes – Oncology
RETROSPECTIVE REVIEW OF NEUROLOGICAL MANIFESTATIONS IN 189 PATIENTS DIAGNOSED WITH CLOVES SYNDROME
ATTRIBUTES OF HIGH QUALITY END-OF-LIFE CARE FOR CHILDREN WITH CANCER: A STAKEHOLDER-DRIVEN STUDY
SELUMETINIB IN CHILDREN WITH CLINICALLY ASYMPTOMATIC INOPERABLE NF1 RELATED PLEXIFORM NEUROFIBROMAS
Brittany Glassberg, BS
LAROTRECTINIB EFFICACY AND SAFETY IN PEDIATRIC PATIENTS WITH TRK FUSION CANCER
Catherine M. Albert, MD
Clinical Trials and Outcomes – Hematology
FOLLOW-UP OF HYDROXYUREA (HU) IN INFANTS WITH SICKLE CELL ANEMIA(SCA):FINDINGS FROM BABY HUG STUDIES
Zora R. Rogers, MD
TCD VELOCITIES CONVERSION RATE BASED ON INCREASING HB CONCENTRATION: ANALYSIS FROM THE SCCRIP COHORT
Jeremie H. Estepp, MD
HOSPITALIZATION FOR IRON DEFICIENCY ANEMIA IN YOUNG CHILDREN: A MULTICENTER ANALYSIS
Julia Segal, MD
THE SHWACHMAN-DIAMOND SYNDROME REGISTRY: 10 YEAR UPDATE
Elissa Furutani, MD
Basic Science and Clinical Outcomes in Hemostasis, Thrombosis, and Red Cell Pathology
MIR29B MEDIATES EPIGENETIC MECHANISMS OF HBG GENE ACTIVATION IN SICKLE CELL DISEASE
Athena Starlard-Davenport, PhD
OUTCOMES OF RIGHT ATRIAL THROMBI IN CHILDREN; AN OBSERVATIONAL COHORT STUDY
Benjamin T. Barnes, MD
LONG TERM NEUROLOGICAL OUTCOMES IN PEDIATRIC THROMBOTIC THROMBOCYTOPENIC PURPURA
Sara Graciaa, CPNP
Educational Support Acknowledgment
ASPHO extends it appreciation to the following organization for its educational support of the Virtual Learning Series: